Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocardial Ischemia | 78 | 2024 | 2110 | 11.560 |
Why?
|
Coronary Artery Disease | 97 | 2024 | 6403 | 8.320 |
Why?
|
Angioplasty, Balloon, Coronary | 56 | 2021 | 1723 | 5.820 |
Why?
|
Myocardial Revascularization | 42 | 2024 | 790 | 5.790 |
Why?
|
Myocardial Infarction | 132 | 2024 | 11458 | 4.760 |
Why?
|
Coronary Artery Bypass | 47 | 2023 | 2188 | 4.670 |
Why?
|
Angina Pectoris | 42 | 2023 | 959 | 4.660 |
Why?
|
Cardiovascular Agents | 35 | 2024 | 840 | 4.400 |
Why?
|
Niacin | 14 | 2024 | 118 | 4.350 |
Why?
|
Cholesterol, HDL | 20 | 2023 | 1810 | 3.130 |
Why?
|
Hypolipidemic Agents | 16 | 2019 | 609 | 3.120 |
Why?
|
Angina, Unstable | 33 | 2022 | 888 | 3.060 |
Why?
|
Acute Coronary Syndrome | 30 | 2024 | 2190 | 2.710 |
Why?
|
Coronary Disease | 50 | 2023 | 5911 | 2.570 |
Why?
|
Hypertriglyceridemia | 6 | 2024 | 293 | 2.520 |
Why?
|
Platelet Aggregation Inhibitors | 35 | 2021 | 2746 | 2.370 |
Why?
|
Cardiovascular Diseases | 37 | 2024 | 15498 | 1.960 |
Why?
|
Electrocardiography | 72 | 2018 | 6346 | 1.960 |
Why?
|
Coronary Angiography | 50 | 2024 | 4470 | 1.950 |
Why?
|
Dyslipidemias | 7 | 2022 | 868 | 1.860 |
Why?
|
Calcium Channel Blockers | 16 | 2020 | 694 | 1.630 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 20 | 2024 | 3245 | 1.520 |
Why?
|
Vasodilator Agents | 12 | 2017 | 973 | 1.510 |
Why?
|
Ischemia | 16 | 2023 | 1885 | 1.500 |
Why?
|
Diltiazem | 21 | 2001 | 131 | 1.500 |
Why?
|
Eicosapentaenoic Acid | 8 | 2024 | 561 | 1.480 |
Why?
|
Myocardial Perfusion Imaging | 9 | 2022 | 575 | 1.350 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 9 | 2019 | 1068 | 1.300 |
Why?
|
Nitrates | 8 | 2017 | 263 | 1.290 |
Why?
|
Practice Guidelines as Topic | 27 | 2024 | 7390 | 1.280 |
Why?
|
Adrenergic beta-Antagonists | 23 | 2020 | 1241 | 1.280 |
Why?
|
Randomized Controlled Trials as Topic | 44 | 2024 | 10203 | 1.250 |
Why?
|
Coronary Vessels | 12 | 2022 | 3095 | 1.230 |
Why?
|
Drug-Eluting Stents | 7 | 2016 | 681 | 1.190 |
Why?
|
Ticlopidine | 15 | 2016 | 730 | 1.190 |
Why?
|
Exercise Test | 26 | 2020 | 2127 | 1.180 |
Why?
|
Humans | 403 | 2024 | 760740 | 1.160 |
Why?
|
Terminology as Topic | 2 | 2024 | 1528 | 1.130 |
Why?
|
Triglycerides | 14 | 2024 | 2459 | 1.110 |
Why?
|
Treatment Outcome | 107 | 2024 | 64572 | 1.090 |
Why?
|
Coronary Stenosis | 10 | 2018 | 794 | 1.080 |
Why?
|
Atherosclerosis | 14 | 2024 | 3400 | 1.050 |
Why?
|
Thrombolytic Therapy | 13 | 2018 | 2055 | 0.970 |
Why?
|
Hyperlipidemias | 4 | 2024 | 770 | 0.940 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 11 | 2011 | 577 | 0.900 |
Why?
|
Nitroglycerin | 3 | 2015 | 329 | 0.850 |
Why?
|
Risk Assessment | 44 | 2024 | 23974 | 0.850 |
Why?
|
Aspirin | 16 | 2018 | 3127 | 0.840 |
Why?
|
Drug Therapy, Combination | 33 | 2018 | 6305 | 0.840 |
Why?
|
Fibrinolytic Agents | 9 | 2014 | 2073 | 0.810 |
Why?
|
Fractional Flow Reserve, Myocardial | 3 | 2022 | 324 | 0.810 |
Why?
|
Vasodilation | 2 | 2017 | 962 | 0.780 |
Why?
|
Secondary Prevention | 10 | 2018 | 1470 | 0.770 |
Why?
|
Clinical Trials as Topic | 23 | 2024 | 7995 | 0.770 |
Why?
|
Coronary Circulation | 5 | 2021 | 1569 | 0.760 |
Why?
|
Risk Factors | 84 | 2024 | 74128 | 0.740 |
Why?
|
Diabetes Mellitus | 9 | 2023 | 5838 | 0.730 |
Why?
|
Cholesterol, LDL | 14 | 2023 | 2378 | 0.730 |
Why?
|
Renal Insufficiency, Chronic | 10 | 2022 | 2252 | 0.690 |
Why?
|
Coronary Occlusion | 1 | 2023 | 304 | 0.670 |
Why?
|
Time Factors | 56 | 2024 | 39908 | 0.670 |
Why?
|
Stents | 12 | 2021 | 3177 | 0.670 |
Why?
|
Translating | 1 | 2020 | 143 | 0.660 |
Why?
|
Disease Management | 6 | 2022 | 2506 | 0.650 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2019 | 127 | 0.630 |
Why?
|
Exercise Tolerance | 5 | 2018 | 836 | 0.620 |
Why?
|
Delivery of Health Care | 6 | 2021 | 5334 | 0.610 |
Why?
|
Vascular Diseases | 3 | 2023 | 1159 | 0.610 |
Why?
|
Unnecessary Procedures | 1 | 2021 | 414 | 0.600 |
Why?
|
Middle Aged | 159 | 2024 | 220603 | 0.600 |
Why?
|
Syndrome | 14 | 2021 | 3268 | 0.590 |
Why?
|
Aged | 131 | 2024 | 169092 | 0.590 |
Why?
|
Lipoproteins | 3 | 2018 | 879 | 0.580 |
Why?
|
Risk Reduction Behavior | 6 | 2022 | 1110 | 0.580 |
Why?
|
Myocardial Reperfusion | 3 | 2008 | 338 | 0.570 |
Why?
|
Male | 184 | 2024 | 360402 | 0.560 |
Why?
|
Anticholesteremic Agents | 8 | 2018 | 967 | 0.560 |
Why?
|
Diabetes Mellitus, Type 2 | 14 | 2023 | 12143 | 0.550 |
Why?
|
Female | 195 | 2024 | 392203 | 0.540 |
Why?
|
Delayed-Action Preparations | 8 | 2019 | 962 | 0.530 |
Why?
|
Reimbursement Mechanisms | 1 | 2021 | 667 | 0.510 |
Why?
|
Quality of Life | 28 | 2024 | 13359 | 0.500 |
Why?
|
Tyrosine | 4 | 2008 | 1440 | 0.490 |
Why?
|
Prognosis | 39 | 2024 | 29601 | 0.480 |
Why?
|
Plaque, Atherosclerotic | 2 | 2024 | 1533 | 0.480 |
Why?
|
Thrombosis | 6 | 2018 | 2942 | 0.480 |
Why?
|
Health Care Reform | 2 | 2017 | 1247 | 0.470 |
Why?
|
Insulin | 3 | 2016 | 6593 | 0.470 |
Why?
|
Diabetic Angiopathies | 4 | 2015 | 803 | 0.460 |
Why?
|
Diagnostic Techniques, Cardiovascular | 2 | 2016 | 148 | 0.460 |
Why?
|
Testosterone | 3 | 2023 | 2472 | 0.450 |
Why?
|
Chelation Therapy | 1 | 2013 | 77 | 0.440 |
Why?
|
Health Expenditures | 2 | 2019 | 2363 | 0.440 |
Why?
|
Cardiomyopathies | 2 | 2023 | 1948 | 0.430 |
Why?
|
Kaplan-Meier Estimate | 18 | 2020 | 6473 | 0.430 |
Why?
|
Coronary Restenosis | 3 | 2012 | 396 | 0.430 |
Why?
|
Heart Rate | 15 | 2018 | 4181 | 0.420 |
Why?
|
Follow-Up Studies | 42 | 2024 | 39062 | 0.420 |
Why?
|
Peripheral Arterial Disease | 4 | 2019 | 1271 | 0.420 |
Why?
|
Acetanilides | 3 | 2011 | 169 | 0.420 |
Why?
|
Heart Diseases | 4 | 2012 | 2778 | 0.410 |
Why?
|
Androgens | 1 | 2020 | 1285 | 0.410 |
Why?
|
Cardiology | 6 | 2023 | 1656 | 0.410 |
Why?
|
Combined Modality Therapy | 14 | 2018 | 8516 | 0.410 |
Why?
|
Survival Rate | 17 | 2023 | 12719 | 0.400 |
Why?
|
Health Status | 12 | 2024 | 4076 | 0.400 |
Why?
|
Chelating Agents | 1 | 2013 | 387 | 0.400 |
Why?
|
Glucose Intolerance | 1 | 2016 | 575 | 0.390 |
Why?
|
Hypoglycemic Agents | 5 | 2019 | 3085 | 0.390 |
Why?
|
Multicenter Studies as Topic | 10 | 2010 | 1700 | 0.380 |
Why?
|
Cause of Death | 7 | 2023 | 3683 | 0.380 |
Why?
|
Double-Blind Method | 25 | 2023 | 12333 | 0.380 |
Why?
|
Coronary Care Units | 4 | 2008 | 235 | 0.370 |
Why?
|
Severity of Illness Index | 23 | 2024 | 15829 | 0.370 |
Why?
|
Piperazines | 6 | 2013 | 2521 | 0.370 |
Why?
|
Predictive Value of Tests | 18 | 2024 | 15250 | 0.370 |
Why?
|
Verapamil | 3 | 2001 | 242 | 0.360 |
Why?
|
Goals | 2 | 2024 | 708 | 0.350 |
Why?
|
Endpoint Determination | 5 | 2011 | 590 | 0.350 |
Why?
|
Lipoproteins, HDL | 5 | 2018 | 675 | 0.340 |
Why?
|
Simvastatin | 6 | 2019 | 346 | 0.340 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 8 | 2019 | 1517 | 0.340 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1896 | 0.340 |
Why?
|
Stroke | 22 | 2024 | 9715 | 0.330 |
Why?
|
Ventricular Dysfunction, Left | 8 | 2023 | 2118 | 0.320 |
Why?
|
Coronary Thrombosis | 4 | 2011 | 440 | 0.320 |
Why?
|
Gemfibrozil | 4 | 2003 | 30 | 0.310 |
Why?
|
Creatine Kinase | 15 | 2024 | 685 | 0.310 |
Why?
|
Perioperative Care | 2 | 2017 | 1037 | 0.310 |
Why?
|
Evidence-Based Medicine | 8 | 2024 | 3680 | 0.310 |
Why?
|
Anticoagulants | 6 | 2009 | 4785 | 0.310 |
Why?
|
Tachycardia, Supraventricular | 1 | 2011 | 266 | 0.300 |
Why?
|
Physician-Patient Relations | 1 | 2021 | 3239 | 0.300 |
Why?
|
Drugs, Investigational | 1 | 2010 | 212 | 0.300 |
Why?
|
Echocardiography, Stress | 4 | 2015 | 134 | 0.300 |
Why?
|
Cost-Benefit Analysis | 11 | 2023 | 5493 | 0.300 |
Why?
|
United States | 37 | 2023 | 72292 | 0.300 |
Why?
|
Hospitals, Veterans | 4 | 2002 | 395 | 0.290 |
Why?
|
Patient Admission | 3 | 2013 | 1365 | 0.280 |
Why?
|
Laboratories | 1 | 2011 | 458 | 0.280 |
Why?
|
Exercise Therapy | 1 | 2014 | 929 | 0.280 |
Why?
|
Fibrinolysis | 2 | 2007 | 331 | 0.280 |
Why?
|
Survival Analysis | 18 | 2020 | 10072 | 0.270 |
Why?
|
Hyperglycemia | 2 | 2013 | 1375 | 0.270 |
Why?
|
Enzyme Inhibitors | 5 | 2014 | 3705 | 0.270 |
Why?
|
Hypogonadism | 2 | 2023 | 798 | 0.260 |
Why?
|
Heart Conduction System | 2 | 2001 | 992 | 0.260 |
Why?
|
Decision Trees | 4 | 2020 | 504 | 0.260 |
Why?
|
Guideline Adherence | 7 | 2019 | 2218 | 0.260 |
Why?
|
Stroke Volume | 7 | 2016 | 5486 | 0.260 |
Why?
|
Tricuspid Valve Insufficiency | 2 | 2024 | 352 | 0.260 |
Why?
|
Postoperative Complications | 7 | 2017 | 15609 | 0.250 |
Why?
|
Pacemaker, Artificial | 3 | 2024 | 805 | 0.250 |
Why?
|
Registries | 6 | 2021 | 8209 | 0.250 |
Why?
|
Digoxin | 3 | 2000 | 246 | 0.250 |
Why?
|
Television | 1 | 2008 | 407 | 0.250 |
Why?
|
Hypertension | 10 | 2023 | 8532 | 0.240 |
Why?
|
Tachycardia, Ventricular | 2 | 2011 | 1261 | 0.240 |
Why?
|
Anti-Arrhythmia Agents | 4 | 2017 | 763 | 0.240 |
Why?
|
United States Department of Veterans Affairs | 7 | 2022 | 928 | 0.240 |
Why?
|
Thiophenes | 3 | 2013 | 569 | 0.230 |
Why?
|
Angiotensin Receptor Antagonists | 3 | 2021 | 1040 | 0.230 |
Why?
|
Mitral Valve Insufficiency | 2 | 2024 | 1400 | 0.230 |
Why?
|
Microcirculation | 1 | 2009 | 1272 | 0.230 |
Why?
|
Recurrence | 18 | 2018 | 8426 | 0.230 |
Why?
|
Vascular Surgical Procedures | 2 | 2023 | 1489 | 0.220 |
Why?
|
Government Regulation | 1 | 2008 | 524 | 0.220 |
Why?
|
Hemorrhage | 9 | 2024 | 3418 | 0.220 |
Why?
|
History, 21st Century | 4 | 2018 | 1566 | 0.220 |
Why?
|
Antihypertensive Agents | 3 | 2019 | 2018 | 0.210 |
Why?
|
Acute Disease | 13 | 2005 | 7236 | 0.210 |
Why?
|
Lipids | 2 | 2009 | 3332 | 0.210 |
Why?
|
Insurance, Health | 2 | 2019 | 2495 | 0.200 |
Why?
|
Incidence | 12 | 2021 | 21339 | 0.200 |
Why?
|
Cardiology Service, Hospital | 1 | 2004 | 239 | 0.200 |
Why?
|
Aged, 80 and over | 22 | 2024 | 58919 | 0.200 |
Why?
|
Hospitals, Urban | 1 | 2004 | 500 | 0.200 |
Why?
|
Blood Glucose | 2 | 2016 | 6390 | 0.200 |
Why?
|
Proportional Hazards Models | 15 | 2020 | 12448 | 0.200 |
Why?
|
Hippocratic Oath | 1 | 2021 | 16 | 0.190 |
Why?
|
Heart Failure | 9 | 2023 | 11670 | 0.190 |
Why?
|
Chronic Disease | 10 | 2024 | 9310 | 0.190 |
Why?
|
Glomerular Filtration Rate | 2 | 2021 | 2174 | 0.190 |
Why?
|
History, 20th Century | 4 | 2018 | 2764 | 0.190 |
Why?
|
Prospective Studies | 24 | 2021 | 54364 | 0.190 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2021 | 10754 | 0.180 |
Why?
|
Cardiac Resynchronization Therapy | 2 | 2024 | 557 | 0.180 |
Why?
|
Defibrillators, Implantable | 2 | 2024 | 1483 | 0.180 |
Why?
|
Comorbidity | 11 | 2019 | 10507 | 0.180 |
Why?
|
Drug Therapy | 2 | 2010 | 503 | 0.180 |
Why?
|
Ontario | 2 | 2024 | 397 | 0.180 |
Why?
|
Felodipine | 2 | 1997 | 3 | 0.170 |
Why?
|
Phenethylamines | 1 | 2000 | 95 | 0.170 |
Why?
|
Peptides | 4 | 2008 | 4354 | 0.170 |
Why?
|
Blood Platelets | 1 | 2010 | 2478 | 0.160 |
Why?
|
Brugada Syndrome | 2 | 2011 | 91 | 0.160 |
Why?
|
Referral and Consultation | 3 | 2022 | 3599 | 0.160 |
Why?
|
Risk | 8 | 2018 | 9603 | 0.160 |
Why?
|
Cardiomegaly | 3 | 1992 | 590 | 0.160 |
Why?
|
Preventive Medicine | 2 | 2017 | 245 | 0.160 |
Why?
|
Pyridones | 1 | 2024 | 808 | 0.160 |
Why?
|
Troponin | 4 | 2011 | 502 | 0.160 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2019 | 277 | 0.160 |
Why?
|
Immunoglobulin Fab Fragments | 3 | 2008 | 445 | 0.160 |
Why?
|
Isoenzymes | 11 | 2005 | 1687 | 0.150 |
Why?
|
Data Interpretation, Statistical | 2 | 2007 | 2689 | 0.150 |
Why?
|
Creatine Kinase, MB Form | 3 | 2020 | 202 | 0.150 |
Why?
|
Research Design | 8 | 2019 | 6174 | 0.150 |
Why?
|
Diagnosis, Differential | 5 | 2011 | 12966 | 0.150 |
Why?
|
Exercise | 4 | 2018 | 5886 | 0.150 |
Why?
|
Sodium Channel Blockers | 1 | 2019 | 172 | 0.150 |
Why?
|
Hospitals | 1 | 2011 | 3879 | 0.150 |
Why?
|
Enalapril | 2 | 1997 | 312 | 0.150 |
Why?
|
Veterans | 5 | 2022 | 2649 | 0.150 |
Why?
|
Eating | 1 | 2024 | 1535 | 0.150 |
Why?
|
Hormone Replacement Therapy | 1 | 2023 | 751 | 0.140 |
Why?
|
Thoracic Surgery | 1 | 2024 | 722 | 0.140 |
Why?
|
Cohort Studies | 10 | 2023 | 41464 | 0.140 |
Why?
|
Blood Pressure | 10 | 2019 | 8473 | 0.140 |
Why?
|
Coronary Sinus | 1 | 2017 | 84 | 0.140 |
Why?
|
Health Services Misuse | 1 | 2019 | 244 | 0.140 |
Why?
|
Oxygen Consumption | 2 | 2017 | 1866 | 0.140 |
Why?
|
Brain Ischemia | 4 | 2018 | 3030 | 0.140 |
Why?
|
Internationality | 1 | 2022 | 1000 | 0.130 |
Why?
|
Life Style | 4 | 2019 | 3907 | 0.130 |
Why?
|
Cardiopulmonary Bypass | 1 | 2001 | 1092 | 0.130 |
Why?
|
Outpatients | 2 | 2021 | 1596 | 0.130 |
Why?
|
Age Factors | 9 | 2019 | 18381 | 0.130 |
Why?
|
Odds Ratio | 6 | 2016 | 9644 | 0.130 |
Why?
|
Hospital Mortality | 6 | 2013 | 5292 | 0.130 |
Why?
|
Administration, Sublingual | 1 | 2015 | 59 | 0.130 |
Why?
|
Canada | 6 | 2015 | 2120 | 0.130 |
Why?
|
Brachiocephalic Veins | 1 | 2015 | 21 | 0.130 |
Why?
|
Benzazepines | 3 | 1986 | 310 | 0.130 |
Why?
|
Disease Progression | 6 | 2011 | 13495 | 0.120 |
Why?
|
Meta-Analysis as Topic | 3 | 2001 | 1380 | 0.120 |
Why?
|
Azetidines | 2 | 2013 | 142 | 0.120 |
Why?
|
Tablets | 1 | 2015 | 148 | 0.120 |
Why?
|
Bioprosthesis | 2 | 1994 | 591 | 0.120 |
Why?
|
Haptoglobins | 1 | 2016 | 165 | 0.120 |
Why?
|
Chi-Square Distribution | 5 | 2013 | 3410 | 0.120 |
Why?
|
Clinical Protocols | 5 | 2019 | 1436 | 0.120 |
Why?
|
Health Care Costs | 2 | 2023 | 3238 | 0.120 |
Why?
|
Resource Allocation | 1 | 2017 | 350 | 0.120 |
Why?
|
Intention to Treat Analysis | 1 | 2016 | 413 | 0.120 |
Why?
|
Chemistry, Pharmaceutical | 2 | 2015 | 274 | 0.120 |
Why?
|
North America | 4 | 2013 | 1273 | 0.120 |
Why?
|
Adult | 43 | 2023 | 220995 | 0.120 |
Why?
|
Medicare | 1 | 2013 | 6774 | 0.120 |
Why?
|
Cardiac Care Facilities | 2 | 2011 | 34 | 0.120 |
Why?
|
Retrospective Studies | 24 | 2024 | 80583 | 0.120 |
Why?
|
Bayes Theorem | 4 | 2024 | 2327 | 0.120 |
Why?
|
Sex Factors | 6 | 2020 | 10549 | 0.120 |
Why?
|
Cardiovascular System | 1 | 2021 | 834 | 0.110 |
Why?
|
Medical History Taking | 2 | 2015 | 773 | 0.110 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 1999 | 851 | 0.110 |
Why?
|
Cholesterol | 2 | 2013 | 2902 | 0.110 |
Why?
|
Pyrazoles | 1 | 2024 | 2008 | 0.110 |
Why?
|
Medication Adherence | 3 | 2022 | 2175 | 0.110 |
Why?
|
Echocardiography | 4 | 2022 | 4987 | 0.110 |
Why?
|
Pericarditis | 2 | 1985 | 134 | 0.100 |
Why?
|
Death, Sudden, Cardiac | 2 | 2018 | 1551 | 0.100 |
Why?
|
Aerosols | 1 | 2015 | 635 | 0.100 |
Why?
|
Angioplasty | 2 | 2015 | 355 | 0.100 |
Why?
|
Diabetes Complications | 3 | 2011 | 1315 | 0.100 |
Why?
|
Multivariate Analysis | 7 | 2016 | 12043 | 0.100 |
Why?
|
Apolipoprotein A-II | 1 | 1992 | 41 | 0.100 |
Why?
|
Connecticut | 2 | 2004 | 364 | 0.100 |
Why?
|
Early Diagnosis | 2 | 2015 | 1185 | 0.100 |
Why?
|
Polysaccharides | 2 | 2009 | 1013 | 0.100 |
Why?
|
Societies, Scientific | 1 | 2013 | 222 | 0.100 |
Why?
|
Patient Transfer | 3 | 2008 | 793 | 0.100 |
Why?
|
Myocardial Reperfusion Injury | 1 | 1995 | 481 | 0.100 |
Why?
|
Streptokinase | 1 | 1991 | 186 | 0.090 |
Why?
|
Physician Executives | 1 | 2012 | 134 | 0.090 |
Why?
|
Myocardium | 4 | 2017 | 4725 | 0.090 |
Why?
|
Atrial Fibrillation | 3 | 2024 | 5031 | 0.090 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2013 | 284 | 0.090 |
Why?
|
Radionuclide Ventriculography | 3 | 2002 | 40 | 0.090 |
Why?
|
Heart Valve Prosthesis | 2 | 1994 | 1462 | 0.090 |
Why?
|
Communication Barriers | 1 | 2014 | 414 | 0.090 |
Why?
|
Hospitals, Community | 3 | 2008 | 365 | 0.090 |
Why?
|
Apolipoproteins B | 1 | 1992 | 385 | 0.090 |
Why?
|
Genetic Loci | 1 | 2019 | 2624 | 0.090 |
Why?
|
Genome-Wide Association Study | 2 | 2019 | 12661 | 0.090 |
Why?
|
Sulfonamides | 1 | 2000 | 1977 | 0.090 |
Why?
|
Enoxaparin | 2 | 2009 | 391 | 0.090 |
Why?
|
Hospital Units | 1 | 2011 | 142 | 0.090 |
Why?
|
Prevalence | 6 | 2019 | 15702 | 0.090 |
Why?
|
Baltimore | 1 | 2010 | 231 | 0.090 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 2 | 2014 | 431 | 0.080 |
Why?
|
Recovery of Function | 2 | 2018 | 2977 | 0.080 |
Why?
|
Pyridines | 3 | 2018 | 2875 | 0.080 |
Why?
|
Platelet Membrane Glycoproteins | 1 | 2010 | 284 | 0.080 |
Why?
|
Renal Dialysis | 2 | 2018 | 1795 | 0.080 |
Why?
|
Decision Making | 2 | 2017 | 3919 | 0.080 |
Why?
|
Physical Examination | 1 | 2015 | 1254 | 0.080 |
Why?
|
Adenosine Diphosphate | 1 | 2010 | 422 | 0.080 |
Why?
|
Prostaglandins | 1 | 2010 | 398 | 0.080 |
Why?
|
Angiotensins | 1 | 2009 | 142 | 0.080 |
Why?
|
Labor, Obstetric | 6 | 1968 | 323 | 0.080 |
Why?
|
Atrioventricular Block | 1 | 2010 | 132 | 0.080 |
Why?
|
Nifedipine | 2 | 1988 | 221 | 0.080 |
Why?
|
Health Literacy | 1 | 2014 | 443 | 0.080 |
Why?
|
Logistic Models | 5 | 2016 | 13248 | 0.080 |
Why?
|
Medically Uninsured | 1 | 2014 | 835 | 0.080 |
Why?
|
Parasympathetic Nervous System | 1 | 1989 | 143 | 0.080 |
Why?
|
Cardiac Surgical Procedures | 1 | 2024 | 3621 | 0.080 |
Why?
|
Health Behavior | 2 | 2018 | 2643 | 0.080 |
Why?
|
Kidney Failure, Chronic | 2 | 2018 | 2474 | 0.080 |
Why?
|
Xanthophylls | 1 | 2008 | 94 | 0.080 |
Why?
|
Tachycardia | 1 | 2011 | 597 | 0.080 |
Why?
|
Platelet Function Tests | 1 | 2010 | 271 | 0.080 |
Why?
|
Physical Fitness | 1 | 2013 | 743 | 0.080 |
Why?
|
Patient Selection | 3 | 2009 | 4237 | 0.080 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2010 | 432 | 0.070 |
Why?
|
Decision Support Techniques | 1 | 2018 | 1999 | 0.070 |
Why?
|
Linear Models | 3 | 2016 | 5866 | 0.070 |
Why?
|
Myocardial Contraction | 5 | 1984 | 1515 | 0.070 |
Why?
|
Diagnostic Tests, Routine | 1 | 2013 | 786 | 0.070 |
Why?
|
Quality-Adjusted Life Years | 3 | 2023 | 1723 | 0.070 |
Why?
|
American Heart Association | 2 | 2009 | 1039 | 0.070 |
Why?
|
Animals | 12 | 2019 | 168202 | 0.070 |
Why?
|
Pulmonary Gas Exchange | 1 | 2009 | 379 | 0.070 |
Why?
|
Platelet Aggregation | 1 | 2010 | 771 | 0.070 |
Why?
|
Random Allocation | 8 | 1989 | 2392 | 0.070 |
Why?
|
Causality | 1 | 2013 | 1241 | 0.070 |
Why?
|
Hypercholesterolemia | 2 | 2013 | 1141 | 0.070 |
Why?
|
Heart Neoplasms | 3 | 1987 | 362 | 0.070 |
Why?
|
Venous Thromboembolism | 1 | 2019 | 1866 | 0.070 |
Why?
|
Radiography | 2 | 2016 | 6961 | 0.070 |
Why?
|
Emergency Medical Services | 2 | 2008 | 1921 | 0.070 |
Why?
|
Sympathetic Nervous System | 1 | 1989 | 519 | 0.070 |
Why?
|
Constriction, Pathologic | 3 | 2022 | 1096 | 0.070 |
Why?
|
Drug Administration Schedule | 4 | 2016 | 4845 | 0.070 |
Why?
|
Endothelium, Vascular | 2 | 2008 | 4433 | 0.060 |
Why?
|
Kidney | 2 | 2022 | 7044 | 0.060 |
Why?
|
Heart Rupture | 1 | 1985 | 21 | 0.060 |
Why?
|
Uterus | 5 | 1968 | 649 | 0.060 |
Why?
|
Models, Statistical | 1 | 2020 | 5074 | 0.060 |
Why?
|
Statistics as Topic | 1 | 1992 | 2358 | 0.060 |
Why?
|
Technetium Tc 99m Sestamibi | 2 | 2004 | 174 | 0.060 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2007 | 344 | 0.060 |
Why?
|
Social Class | 1 | 2014 | 1993 | 0.060 |
Why?
|
Electronic Health Records | 2 | 2019 | 4810 | 0.060 |
Why?
|
Length of Stay | 5 | 2021 | 6418 | 0.060 |
Why?
|
Ventricular Function, Left | 3 | 2014 | 3873 | 0.060 |
Why?
|
Heart Ventricles | 4 | 2013 | 3796 | 0.060 |
Why?
|
Hospitalization | 7 | 2016 | 10708 | 0.060 |
Why?
|
Health Care Surveys | 1 | 2011 | 2422 | 0.060 |
Why?
|
Chest Pain | 1 | 2011 | 1091 | 0.060 |
Why?
|
Peripheral Vascular Diseases | 1 | 2007 | 488 | 0.060 |
Why?
|
Antifibrinolytic Agents | 1 | 2007 | 287 | 0.060 |
Why?
|
Physical Exertion | 1 | 1987 | 668 | 0.060 |
Why?
|
Blood Transfusion | 3 | 2008 | 1300 | 0.060 |
Why?
|
Bezafibrate | 1 | 2003 | 14 | 0.060 |
Why?
|
Japan | 1 | 2008 | 1372 | 0.060 |
Why?
|
Ibuprofen | 1 | 1985 | 229 | 0.060 |
Why?
|
Water-Electrolyte Balance | 1 | 2004 | 325 | 0.060 |
Why?
|
Reproducibility of Results | 6 | 2018 | 20077 | 0.050 |
Why?
|
Consensus | 1 | 2013 | 3117 | 0.050 |
Why?
|
Anniversaries and Special Events | 1 | 2004 | 95 | 0.050 |
Why?
|
Coronary Aneurysm | 1 | 2006 | 232 | 0.050 |
Why?
|
Antibodies, Monoclonal | 3 | 2008 | 9171 | 0.050 |
Why?
|
Confidence Intervals | 1 | 2009 | 2925 | 0.050 |
Why?
|
Transdermal Patch | 1 | 2023 | 51 | 0.050 |
Why?
|
Puerperal Disorders | 1 | 2006 | 300 | 0.050 |
Why?
|
Lovastatin | 1 | 2003 | 115 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3798 | 0.050 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2010 | 1650 | 0.050 |
Why?
|
Endocarditis | 2 | 1987 | 348 | 0.050 |
Why?
|
Diatrizoate | 1 | 1982 | 81 | 0.050 |
Why?
|
Laboratories, Hospital | 1 | 2004 | 190 | 0.050 |
Why?
|
New York | 2 | 2019 | 875 | 0.050 |
Why?
|
Feasibility Studies | 3 | 2021 | 5239 | 0.050 |
Why?
|
Cryptococcosis | 1 | 1983 | 103 | 0.050 |
Why?
|
Thallium Radioisotopes | 2 | 2002 | 138 | 0.050 |
Why?
|
Gels | 1 | 2023 | 420 | 0.050 |
Why?
|
Heart | 5 | 2023 | 4403 | 0.050 |
Why?
|
Collagen | 1 | 2010 | 2634 | 0.050 |
Why?
|
Angina Pectoris, Variant | 1 | 1981 | 53 | 0.050 |
Why?
|
Perfusion | 1 | 2006 | 1373 | 0.050 |
Why?
|
Benchmarking | 1 | 2008 | 1045 | 0.050 |
Why?
|
History, 19th Century | 1 | 2004 | 718 | 0.050 |
Why?
|
Health Education | 1 | 2008 | 1049 | 0.050 |
Why?
|
Leg | 2 | 2005 | 1087 | 0.050 |
Why?
|
Cardiac Pacing, Artificial | 2 | 2024 | 852 | 0.050 |
Why?
|
Self Care | 1 | 2006 | 796 | 0.050 |
Why?
|
Sirolimus | 1 | 2008 | 1533 | 0.050 |
Why?
|
Quality of Health Care | 4 | 2009 | 4325 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2019 | 17878 | 0.050 |
Why?
|
Disease-Free Survival | 2 | 2008 | 6807 | 0.050 |
Why?
|
Time | 1 | 2002 | 545 | 0.050 |
Why?
|
Fluid Therapy | 1 | 2004 | 577 | 0.050 |
Why?
|
Health Promotion | 1 | 2013 | 2206 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2023 | 20556 | 0.040 |
Why?
|
Radionuclide Imaging | 5 | 2011 | 1972 | 0.040 |
Why?
|
Inpatients | 1 | 2012 | 2545 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2019 | 22153 | 0.040 |
Why?
|
Acetates | 1 | 2001 | 321 | 0.040 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2003 | 451 | 0.040 |
Why?
|
Contrast Media | 2 | 2004 | 5305 | 0.040 |
Why?
|
United States Food and Drug Administration | 1 | 2008 | 1661 | 0.040 |
Why?
|
Flow Cytometry | 1 | 2010 | 5863 | 0.040 |
Why?
|
Dystocia | 3 | 1968 | 34 | 0.040 |
Why?
|
State Medicine | 1 | 2021 | 216 | 0.040 |
Why?
|
Health Status Indicators | 1 | 2024 | 970 | 0.040 |
Why?
|
Angioplasty, Balloon | 1 | 2003 | 589 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2007 | 3514 | 0.040 |
Why?
|
Patient Satisfaction | 4 | 2013 | 3451 | 0.040 |
Why?
|
Factor V | 1 | 2019 | 167 | 0.040 |
Why?
|
Review Literature as Topic | 1 | 2020 | 347 | 0.040 |
Why?
|
Cardiac Complexes, Premature | 1 | 1978 | 63 | 0.040 |
Why?
|
Critical Pathways | 1 | 2002 | 474 | 0.040 |
Why?
|
Hemangioma | 1 | 1983 | 727 | 0.040 |
Why?
|
Ambulatory Care | 1 | 2009 | 2768 | 0.040 |
Why?
|
Cross-Over Studies | 3 | 2013 | 2079 | 0.040 |
Why?
|
Smoking Cessation | 3 | 2018 | 2056 | 0.040 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2004 | 831 | 0.040 |
Why?
|
Michigan | 1 | 2019 | 339 | 0.040 |
Why?
|
Denmark | 1 | 2000 | 770 | 0.040 |
Why?
|
Systole | 1 | 1980 | 935 | 0.040 |
Why?
|
Program Development | 1 | 2004 | 1293 | 0.040 |
Why?
|
Thromboembolism | 1 | 2024 | 991 | 0.040 |
Why?
|
New Zealand | 1 | 2018 | 358 | 0.040 |
Why?
|
Florida | 1 | 2019 | 429 | 0.040 |
Why?
|
Pulmonary Edema | 1 | 2000 | 407 | 0.040 |
Why?
|
Arrhythmias, Cardiac | 3 | 2018 | 2234 | 0.040 |
Why?
|
Oxidative Stress | 1 | 2008 | 3115 | 0.030 |
Why?
|
Femoral Artery | 1 | 2001 | 826 | 0.030 |
Why?
|
Brucella Vaccine | 2 | 1967 | 3 | 0.030 |
Why?
|
Diabetic Nephropathies | 1 | 2004 | 972 | 0.030 |
Why?
|
Uterine Cervical Diseases | 2 | 1967 | 73 | 0.030 |
Why?
|
Brucella abortus | 2 | 1967 | 14 | 0.030 |
Why?
|
Receptors, LDL | 1 | 2019 | 488 | 0.030 |
Why?
|
Algorithms | 5 | 2014 | 14024 | 0.030 |
Why?
|
Retreatment | 1 | 2018 | 596 | 0.030 |
Why?
|
Mass Screening | 1 | 2012 | 5425 | 0.030 |
Why?
|
Cardiac Output | 2 | 1981 | 831 | 0.030 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2017 | 352 | 0.030 |
Why?
|
Suture Techniques | 1 | 2001 | 768 | 0.030 |
Why?
|
Administration, Oral | 1 | 2024 | 4010 | 0.030 |
Why?
|
Republic of Korea | 1 | 2018 | 583 | 0.030 |
Why?
|
Hypotension | 1 | 1982 | 879 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2006 | 2644 | 0.030 |
Why?
|
Hospital Costs | 1 | 2002 | 947 | 0.030 |
Why?
|
Hemodynamics | 4 | 1997 | 4160 | 0.030 |
Why?
|
Smoking | 4 | 2018 | 9054 | 0.030 |
Why?
|
Cardiac Imaging Techniques | 1 | 2018 | 266 | 0.030 |
Why?
|
Lactones | 1 | 2018 | 316 | 0.030 |
Why?
|
Myocardial Stunning | 1 | 1995 | 66 | 0.030 |
Why?
|
Calibration | 1 | 2018 | 817 | 0.030 |
Why?
|
Dextropropoxyphene | 2 | 1966 | 26 | 0.030 |
Why?
|
Drug Interactions | 1 | 2000 | 1415 | 0.030 |
Why?
|
Sweden | 1 | 2018 | 1379 | 0.030 |
Why?
|
Patient Discharge | 1 | 2008 | 3442 | 0.030 |
Why?
|
Myxoma | 2 | 1987 | 114 | 0.030 |
Why?
|
Subcutaneous Tissue | 1 | 2015 | 132 | 0.030 |
Why?
|
Kidney Transplantation | 1 | 2009 | 4218 | 0.030 |
Why?
|
Forecasting | 1 | 2003 | 2924 | 0.030 |
Why?
|
Respiration | 2 | 1989 | 1656 | 0.030 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2004 | 1553 | 0.030 |
Why?
|
Blood Flow Velocity | 1 | 2017 | 1369 | 0.030 |
Why?
|
Population Surveillance | 1 | 2024 | 2597 | 0.030 |
Why?
|
Sex Distribution | 2 | 2009 | 2278 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2024 | 2637 | 0.030 |
Why?
|
Age Distribution | 1 | 1999 | 2872 | 0.030 |
Why?
|
Regression Analysis | 3 | 2013 | 6339 | 0.030 |
Why?
|
Drug Utilization | 1 | 2019 | 1186 | 0.030 |
Why?
|
Cardiotonic Agents | 1 | 1996 | 539 | 0.030 |
Why?
|
Diuretics | 1 | 1996 | 611 | 0.030 |
Why?
|
Research | 1 | 2001 | 1977 | 0.030 |
Why?
|
Body Mass Index | 5 | 2010 | 12942 | 0.030 |
Why?
|
Heparin | 2 | 2008 | 1632 | 0.030 |
Why?
|
Purinergic P2 Receptor Antagonists | 1 | 2012 | 67 | 0.030 |
Why?
|
Renal Insufficiency | 1 | 2018 | 808 | 0.030 |
Why?
|
Oxytocin | 2 | 1967 | 402 | 0.030 |
Why?
|
Radiopharmaceuticals | 2 | 2002 | 2650 | 0.030 |
Why?
|
Drug Packaging | 1 | 1972 | 43 | 0.020 |
Why?
|
Discriminant Analysis | 1 | 2012 | 223 | 0.020 |
Why?
|
Electric Countershock | 1 | 2015 | 532 | 0.020 |
Why?
|
Anesthesia, Obstetrical | 2 | 1965 | 232 | 0.020 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2015 | 290 | 0.020 |
Why?
|
Ankle Brachial Index | 1 | 2012 | 163 | 0.020 |
Why?
|
Obstetric Labor, Premature | 2 | 1970 | 272 | 0.020 |
Why?
|
Treatment Failure | 2 | 2011 | 2635 | 0.020 |
Why?
|
Injections, Intravenous | 2 | 1991 | 1376 | 0.020 |
Why?
|
Drug Evaluation | 1 | 1992 | 641 | 0.020 |
Why?
|
Lung Diseases | 1 | 2001 | 1909 | 0.020 |
Why?
|
Ethylamines | 1 | 1970 | 17 | 0.020 |
Why?
|
Analgesics | 3 | 1968 | 1067 | 0.020 |
Why?
|
Amino Alcohols | 1 | 1970 | 19 | 0.020 |
Why?
|
Sympatholytics | 1 | 1970 | 82 | 0.020 |
Why?
|
Long QT Syndrome | 1 | 2015 | 466 | 0.020 |
Why?
|
Electrodes, Implanted | 1 | 2015 | 838 | 0.020 |
Why?
|
Fetus | 2 | 1968 | 1862 | 0.020 |
Why?
|
Nomograms | 1 | 2012 | 230 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2004 | 3233 | 0.020 |
Why?
|
Thrombectomy | 1 | 2015 | 702 | 0.020 |
Why?
|
Electric Power Supplies | 1 | 2010 | 95 | 0.020 |
Why?
|
Intermittent Claudication | 1 | 2012 | 304 | 0.020 |
Why?
|
Scopolamine | 1 | 1990 | 93 | 0.020 |
Why?
|
Catheterization | 1 | 2015 | 1428 | 0.020 |
Why?
|
Cineangiography | 1 | 1989 | 108 | 0.020 |
Why?
|
Telemetry | 1 | 2010 | 199 | 0.020 |
Why?
|
Research Report | 1 | 2012 | 367 | 0.020 |
Why?
|
Nicotinic Acids | 1 | 1968 | 31 | 0.020 |
Why?
|
Freeze Drying | 2 | 1967 | 101 | 0.020 |
Why?
|
Antithrombins | 1 | 2011 | 292 | 0.020 |
Why?
|
Case Management | 1 | 2010 | 272 | 0.020 |
Why?
|
Down-Regulation | 1 | 2016 | 2916 | 0.020 |
Why?
|
Isosorbide Dinitrate | 1 | 2008 | 34 | 0.020 |
Why?
|
Theophylline | 1 | 1968 | 131 | 0.020 |
Why?
|
Inflammation | 1 | 2008 | 10759 | 0.020 |
Why?
|
Amlodipine | 1 | 2008 | 84 | 0.020 |
Why?
|
Europe | 1 | 1995 | 3415 | 0.020 |
Why?
|
Metoprolol | 1 | 2008 | 90 | 0.020 |
Why?
|
Vascular Patency | 1 | 1991 | 911 | 0.020 |
Why?
|
Consent Forms | 1 | 2008 | 55 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2019 | 1846 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2004 | 3415 | 0.020 |
Why?
|
Monitoring, Physiologic | 2 | 2013 | 1780 | 0.020 |
Why?
|
Erysipelothrix | 1 | 1967 | 3 | 0.020 |
Why?
|
Levallorphan | 1 | 1967 | 1 | 0.020 |
Why?
|
Microbiology | 1 | 1968 | 70 | 0.020 |
Why?
|
Meperidine | 1 | 1967 | 38 | 0.020 |
Why?
|
Muscular Diseases | 1 | 2011 | 552 | 0.020 |
Why?
|
Propensity Score | 1 | 2014 | 1912 | 0.020 |
Why?
|
Probability | 1 | 2012 | 2475 | 0.020 |
Why?
|
Dermoid Cyst | 1 | 1967 | 92 | 0.020 |
Why?
|
Muscles | 2 | 1968 | 1573 | 0.020 |
Why?
|
Hematocrit | 1 | 2008 | 623 | 0.020 |
Why?
|
Abortion, Habitual | 1 | 1967 | 61 | 0.020 |
Why?
|
Lipoproteins, LDL | 1 | 2009 | 642 | 0.020 |
Why?
|
Dogs | 3 | 1981 | 3837 | 0.020 |
Why?
|
Uterine Diseases | 1 | 1967 | 108 | 0.020 |
Why?
|
Prosthesis Implantation | 1 | 2010 | 591 | 0.020 |
Why?
|
Muscle Contraction | 2 | 1968 | 1200 | 0.020 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 1967 | 147 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2008 | 1624 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2022 | 6483 | 0.020 |
Why?
|
Labor, Induced | 1 | 1967 | 151 | 0.020 |
Why?
|
Labor Pain | 1 | 1965 | 15 | 0.020 |
Why?
|
Sodium Chloride | 1 | 1967 | 586 | 0.020 |
Why?
|
Clinical Enzyme Tests | 1 | 1984 | 113 | 0.020 |
Why?
|
Pregnancy | 13 | 2006 | 29869 | 0.010 |
Why?
|
Posture | 1 | 1989 | 956 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1993 | 6223 | 0.010 |
Why?
|
Obstetric Labor Complications | 1 | 1967 | 236 | 0.010 |
Why?
|
Heart Septum | 1 | 1985 | 299 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2008 | 1575 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3351 | 0.010 |
Why?
|
Obesity | 1 | 2006 | 12934 | 0.010 |
Why?
|
Mycoplasma pneumoniae | 1 | 1983 | 43 | 0.010 |
Why?
|
Morbidity | 1 | 2009 | 1750 | 0.010 |
Why?
|
Parasympatholytics | 1 | 1963 | 88 | 0.010 |
Why?
|
Pharmacology | 1 | 1963 | 99 | 0.010 |
Why?
|
Heart Atria | 2 | 1987 | 1333 | 0.010 |
Why?
|
Pneumonia, Mycoplasma | 1 | 1983 | 50 | 0.010 |
Why?
|
Flucytosine | 1 | 1983 | 33 | 0.010 |
Why?
|
Oxytocics | 1 | 1963 | 67 | 0.010 |
Why?
|
Anesthesia | 2 | 1965 | 1591 | 0.010 |
Why?
|
Amiodarone | 1 | 2004 | 217 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2019 | 26065 | 0.010 |
Why?
|
Muscle Relaxants, Central | 1 | 1963 | 93 | 0.010 |
Why?
|
Amphotericin B | 1 | 1983 | 142 | 0.010 |
Why?
|
Pain | 2 | 1968 | 5062 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2007 | 1335 | 0.010 |
Why?
|
Streptococcal Infections | 1 | 1987 | 617 | 0.010 |
Why?
|
Emergency Treatment | 1 | 2006 | 495 | 0.010 |
Why?
|
Dietary Fats | 1 | 2010 | 1995 | 0.010 |
Why?
|
Angiography | 1 | 1987 | 1595 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2013 | 2812 | 0.010 |
Why?
|
Reference Values | 1 | 1989 | 4919 | 0.010 |
Why?
|
Primary Prevention | 1 | 2009 | 1185 | 0.010 |
Why?
|
Complement C4 | 1 | 1982 | 216 | 0.010 |
Why?
|
Arteries | 1 | 1967 | 1120 | 0.010 |
Why?
|
Women's Health | 1 | 2011 | 2066 | 0.010 |
Why?
|
Genotype | 1 | 2016 | 12977 | 0.010 |
Why?
|
Heart Block | 1 | 1983 | 384 | 0.010 |
Why?
|
Documentation | 1 | 1968 | 896 | 0.010 |
Why?
|
Early Ambulation | 1 | 2001 | 49 | 0.010 |
Why?
|
Motor Activity | 1 | 2011 | 2714 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 22117 | 0.010 |
Why?
|
Societies, Medical | 1 | 1992 | 3901 | 0.010 |
Why?
|
Complement C3 | 1 | 1982 | 434 | 0.010 |
Why?
|
Equipment Safety | 1 | 2001 | 249 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2011 | 3820 | 0.010 |
Why?
|
Internet | 1 | 2011 | 3094 | 0.010 |
Why?
|
Mortality | 1 | 2010 | 2899 | 0.010 |
Why?
|
Aneurysm, False | 1 | 2001 | 255 | 0.010 |
Why?
|
Equipment Failure Analysis | 1 | 2001 | 843 | 0.010 |
Why?
|
Pulse | 2 | 1970 | 217 | 0.010 |
Why?
|
Anemia | 1 | 2008 | 1504 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 1990 | 2569 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 1978 | 306 | 0.010 |
Why?
|
Adolescent | 4 | 2006 | 88247 | 0.010 |
Why?
|
Critical Care | 1 | 2010 | 2691 | 0.010 |
Why?
|
Cardiac Volume | 1 | 1978 | 196 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2013 | 14599 | 0.010 |
Why?
|
Obstetrics | 1 | 1963 | 666 | 0.010 |
Why?
|
Hematoma | 1 | 2001 | 762 | 0.010 |
Why?
|
Arterial Occlusive Diseases | 1 | 1980 | 748 | 0.010 |
Why?
|
Observer Variation | 1 | 2002 | 2607 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2010 | 4010 | 0.010 |
Why?
|
Emotions | 1 | 1968 | 2741 | 0.010 |
Why?
|
Methods | 2 | 1972 | 1065 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2014 | 36401 | 0.010 |
Why?
|
Physical Endurance | 1 | 1997 | 366 | 0.010 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1967 | 2020 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2004 | 14649 | 0.010 |
Why?
|
Home Care Services | 1 | 1981 | 648 | 0.010 |
Why?
|
Hormones | 1 | 1997 | 869 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 1967 | 2948 | 0.010 |
Why?
|
Aortic Valve | 1 | 1983 | 1955 | 0.010 |
Why?
|
Mice | 1 | 2019 | 81368 | 0.010 |
Why?
|
Reoperation | 1 | 1983 | 4300 | 0.010 |
Why?
|
Germany, East | 1 | 1972 | 6 | 0.010 |
Why?
|
Surgical Wound Infection | 1 | 2001 | 1529 | 0.010 |
Why?
|
Electricity | 1 | 1972 | 175 | 0.010 |
Why?
|
Aorta, Thoracic | 1 | 1978 | 1096 | 0.010 |
Why?
|
Immune Sera | 1 | 1972 | 605 | 0.010 |
Why?
|
Diet | 1 | 2009 | 8049 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1967 | 4021 | 0.010 |
Why?
|
Propanolamines | 1 | 1991 | 163 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2006 | 4488 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 1967 | 4849 | 0.010 |
Why?
|
Uterine Rupture | 1 | 1970 | 65 | 0.010 |
Why?
|
Magnetics | 1 | 1972 | 597 | 0.010 |
Why?
|
Spirometry | 1 | 1972 | 928 | 0.010 |
Why?
|
Electrocardiography, Ambulatory | 1 | 1991 | 574 | 0.000 |
Why?
|
Fetal Heart | 1 | 1970 | 281 | 0.000 |
Why?
|
Placebos | 1 | 1993 | 1667 | 0.000 |
Why?
|
Administration, Cutaneous | 1 | 1990 | 712 | 0.000 |
Why?
|
Psychophysiology | 1 | 1968 | 135 | 0.000 |
Why?
|
Actuarial Analysis | 1 | 1987 | 372 | 0.000 |
Why?
|
Neurophysiology | 1 | 1968 | 144 | 0.000 |
Why?
|
Injections, Intra-Arterial | 1 | 1967 | 181 | 0.000 |
Why?
|
Epinephrine | 1 | 1970 | 792 | 0.000 |
Why?
|
Genital Neoplasms, Female | 1 | 1972 | 532 | 0.000 |
Why?
|
Respiratory Tract Diseases | 1 | 1972 | 750 | 0.000 |
Why?
|
Bacteriology | 1 | 1946 | 9 | 0.000 |
Why?
|
Umbilical Arteries | 1 | 1967 | 79 | 0.000 |
Why?
|
Electrocoagulation | 1 | 1967 | 152 | 0.000 |
Why?
|
Phenols | 1 | 1970 | 516 | 0.000 |
Why?
|
Oscillometry | 1 | 1967 | 150 | 0.000 |
Why?
|
Vagina | 1 | 1972 | 841 | 0.000 |
Why?
|
Uterine Inertia | 1 | 1966 | 29 | 0.000 |
Why?
|
Patients | 1 | 1993 | 906 | 0.000 |
Why?
|
Diazepam | 1 | 1967 | 215 | 0.000 |
Why?
|
Abdomen | 1 | 1972 | 1128 | 0.000 |
Why?
|
Umbilical Cord | 1 | 1967 | 177 | 0.000 |
Why?
|
Water Microbiology | 1 | 1946 | 113 | 0.000 |
Why?
|
Injections, Intramuscular | 1 | 1967 | 555 | 0.000 |
Why?
|
Fungi | 1 | 1968 | 338 | 0.000 |
Why?
|
Autonomic Nervous System | 1 | 1990 | 704 | 0.000 |
Why?
|
Vaginal Smears | 1 | 1967 | 499 | 0.000 |
Why?
|
Viruses | 1 | 1968 | 374 | 0.000 |
Why?
|
Aorta, Abdominal | 1 | 1967 | 625 | 0.000 |
Why?
|
Vaccines | 1 | 1972 | 838 | 0.000 |
Why?
|
Prednisone | 1 | 1967 | 1562 | 0.000 |
Why?
|
Progesterone | 1 | 1967 | 742 | 0.000 |
Why?
|
Infertility, Female | 1 | 1967 | 760 | 0.000 |
Why?
|
Tomography, Emission-Computed | 1 | 1983 | 1122 | 0.000 |
Why?
|
Water | 1 | 1946 | 1409 | 0.000 |
Why?
|
Delivery, Obstetric | 1 | 1967 | 939 | 0.000 |
Why?
|
Gestational Age | 1 | 1967 | 3577 | 0.000 |
Why?
|
Bacteria | 1 | 1968 | 2192 | 0.000 |
Why?
|
Germany, West | 1 | 1972 | 13 | 0.000 |
Why?
|
Diagnostic Techniques, Surgical | 1 | 1972 | 9 | 0.000 |
Why?
|
Genital Diseases, Female | 1 | 1972 | 192 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1967 | 26183 | 0.000 |
Why?
|